Study Shows Accuracy of Optical Biopsy Over Traditional Endoscopic Biopsy

Mauna Kea Technologies, a global optical biopsy company, recently conducted a study that showed its Cellvizio optical biopsy device had greater accuracy in detecting stomach cancer than traditional endoscopic biopsy.

Advertisement

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The study conducted in Korea found that optical biopsy had a 91.7 percent accuracy rate in detecting stomach cancer, while traditional endoscopic biopsies had an 85.2 percent accuracy rate.

More Articles on Gastroenterology:

Memorial Hermann Northeast Hospital Names Dr. Howard Hamat Chief of Staff
CMS Requires Gastroenterologist to Document Quality of Care
Gastrointestinal Device Market Estimated at $33B by 2023

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.